SCHEMBL5768472

SCHEMBL5768472

Cn1cnc2c(=O)nc(SCc3csc4ccc(Cl)cc34)n(-c3ccc(OC(F)(F)F)cc3)c21

nearest known ligand 0.38

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.36
ABCB1 P08183 1/20 0.35
CYP3A4 P08684 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
UBE2M P61081 1/20 0.33
DCUN1D1 Q96GG9 1/20 0.33
DDR1 Q08345 1/20 0.33
MAPT P10636 1/20 0.33
ALDH1A2 O94788 1/20 0.33
ALDH1A3 P47895 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5769812 0.91 KDM1A (0.40) KDM1AABCB1UBE2MDCUN1D1ALDH1A2
SCHEMBL5768068 0.91 KDM1A (0.36) KDM1AABCB1L3MBTL1UBE2MDCUN1D1
SCHEMBL5438197 0.88 ALDH1A2 (0.39) KDM1AABCB1CYP3A4DDR1ALDH1A2
SCHEMBL5769348 0.81 KDM1A (0.38) KDM1AABCB1UBE2MDCUN1D1ALDH1A2
SCHEMBL5770177 0.80 KDM1A (0.36) KDM1AABCB1UBE2MDCUN1D1MAPT
SCHEMBL5765579 0.79 EPHX1 (0.38) KDM1AABCB1
SCHEMBL5434800 0.78 ALDH1A2 (0.40) KDM1AABCB1L3MBTL1UBE2MDCUN1D1
SCHEMBL5426588 0.78 ALDH1A2 (0.43) KDM1AABCB1ALDH1A2ALDH1A3
SCHEMBL5429211 0.73 ALDH1A2 (0.41) KDM1AABCB1ALDH1A2ALDH1A3
SCHEMBL5441947 0.72 ALDH1A2 (0.41) KDM1ACYP3A4ALDH1A2ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687306-A1 BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2006-08-09 EP disclosed
WO-2005049613-A1 BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2005-06-02 WO disclosed